Tempus AI is accelerating foundation model development by utilizing digital slide archives from Memorial Sloan Kettering Cancer Center and Microsoft Azure.

The entities involved

• Memorial Sloan Kettering Cancer Center →

  cancer treatment and research institution in New York City, United States

  • The FDA approved GSK's Jemperli drug, while Memorial Sloan Kettering Cancer Center was involved in the AZUR-1 trial.Mon 21:02
  • Estée Lauder's Chairman supports cancer research, and Larry Norton is named founding scientific director at Memorial Sloan Kettering.Sat 02:50
• Microsoft →

  American multinational technology corporation

  • IT firms, including Infosys and Capgemini, were suspended from the PERM program amid labor policy changes, while the Trump administration blocked Adobe from green cards.06:44
  • An AI tool study developed by Microsoft AI was published in the journal Science.05:01
• Tempus →

  biotechnology company based in Chicago, Illinois

  • Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.Mon 14:45

Related events

• OpenAI models are now available on Google Cloud, expanding the distribution of AI models across major cloud providers.04:27
• Microsoft AI is testing its models with Meta and DeepSeek, joining Google and OpenAI in AI claims.Thu 21:44
• Gartner and Microsoft discussed enterprise AI trends in a partnership.Jun 29
• Major tech firms announce partnerships and massive investments to accelerate AI adoption, cloud expansion, and data center infrastructure.Jun 8
• Major tech companies are financing massive data center buildouts amid global economic uncertainty and systemic risks.Jul 9